Trials / Completed
CompletedNCT04559100
Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus
Clinical, Radiological, Lung Function, and Quality of Life Characterization of Patients With Severe/Critical Infection by SARS-COV-2 (COVID-19) Virus, After 6 and 12 Months of Hospital Discharge
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 112 (actual)
- Sponsor
- Fundacion Clinica Valle del Lili · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
A descriptive study to characterize clinical, radiological, lung function and quality of life alterations in patients who survived a severe or critical disease caused by SARS-COV-2 virus, who were treated in the intensive care unit of a high complexity institution in Cali, Colombia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | chest radiography | 6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months. |
| RADIATION | thoracic computed tomography scan | 6 and 12 months after hospital discharge, if the patient had a CT scan upon admission to the hospital. If the study is normal at 6 months it will not be repeated at 12 months. |
| DIAGNOSTIC_TEST | spirometry | 6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months. |
| DIAGNOSTIC_TEST | Diffusing capacity of carbon monoxide | 6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months. |
| DIAGNOSTIC_TEST | 6 minute walk test | 6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months. |
| DIAGNOSTIC_TEST | saint george respiratory questionnaire | 6 and 12 months after hospital discharge. |
Timeline
- Start date
- 2020-11-15
- Primary completion
- 2021-11-11
- Completion
- 2022-07-01
- First posted
- 2020-09-22
- Last updated
- 2024-08-28
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT04559100. Inclusion in this directory is not an endorsement.